Abstracts tagged "Lymph node and systemic lupus erythematosus (SLE)"

Abstract Number: 2019 • 2013 ACR/ARHP Annual Meeting
Kikuchi-Fujimoto disease : Features and Outcome Of 91 Patients In France
Guillaume Dumas¹, Virginie Prendki², Julien Haroche³, Patrice Cacoub⁴, Zahir Amoura³, Lionel Galicier⁵, Olivier Meyer⁶, Christophe Rapp⁷, Christophe Deligny⁸, Bertrand Godeau⁹, Elisabeth Aslangul¹⁰, Olivier Lambotte¹¹, Thomas Papo¹², Jacques Pouchot¹³, Mohamed Hamidou¹⁴, Gilles Grateau¹⁵, Eric Hachulla¹⁶, Thierry Carmoi¹⁷, Robin Dhote¹⁸, Magdalena Gerin¹⁹, Arsene Mekinian²⁰, Fréderique Charlotte²¹, Dominique Farge⁵, Thierry Molina²² and Olivier Fain²³, ¹internal medicine, Hôpital d'Instruction des Armées Bégin, Saint Mandé, France, ²internal medicine, Geriatry, Hôpitaux Universitaires de Genève, Genève, Switzerland, ³Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, ⁴Groupe Hospitalier Pitié Salpétrière, Service de Médecine Interne, DHU i2B, Paris, France, ⁵Internal Medicine, Hopital St Louis, AP-HP, Paris, France, ⁶Rheumatology, Bichat University Hospital, Paris, France, ⁷intenal medicine, Hôpital d'Instruction des Armées Bégin, Saint Mandé, France, ⁸Rhumatologie Et Médecine Interne, Centre hospitalier Universitaire de Fort de France, Fort de France, Martinique, ⁹Internal Medicine, University of Paris, AP-HP, Hôpital Mondor Créteil, Creteil, France, ¹⁰internal medicine, hôpital Hotel Dieu, AP-HP, Paris, France, ¹¹Internal Medicine, Hopital Kremlin Bicêtre, Kremlin Bicêtre, France, ¹²Internal Medicine, Bichat Hospital, Paris, Paris, France, ¹³internal medicine, Hôpital Européen Georges Pompidou, AP-HP, Paris, France, ¹⁴CHU Hôtel Dieu, Nantes, Nantes, France, ¹⁵Service De Médecine Interne, Hopital Tenon, Paris, France, ¹⁶Internal Medicine, University Hospital Lilles, Lille CEDEX, France, ¹⁷internal medicine, Hôpital d'Instrcution des Armées du Val de Grace, Paris, France, ¹⁸Internal Medicine, Avicenne University Hospital, Bobigny, France, ¹⁹Internal Medicine, Hôpital Jean Verdier, AP-HP, Bondy, France, ²⁰internal medicine, Hôpital Jean Verdier, AP-HP, Bondy, FL, France, ²¹Department of Anatomic Pathology, Hopital Pitié-Salpétrière, Paris, France, ²²Department of Anatomic Pathology, hôpital Hotel Dieu, AP-HP, Paris, France, ²³Hôpital Saint Antoine, DHU i2B, Service de Médecine Interne, paris, France
Background/Purpose: Kikuchi Fujimoto disease (KFD) constitutes a rare cause of cervical lymphadenitis, usually reported in Asia. Data about this disease are scarce in Europe. The…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].